Press Releases Arcede Pharma AB

Equities

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
0.01 ^SEK	-24.24%		-90.00%	-89.01%

2023	Arcede Pharma Announces CEO Changes	CI
2023	Arcede Pharma and Iconovo AB Takes the Next Step in the Development of a New Treatment for COPD	CI

BioStock: Full focus on financing and new CEO for Arcede	05-22	AQ
BioStock: New results confirmation for Arcede Pharma	05-10	AQ
BioStock: Arcede aims for clinic with TO1	01-08	AQ
BioStock: Arcede Pharma appoints acting CEO	12-21	AQ
BioStock: Arcede proceeds to stability study in collaboration with Iconovo	11-20	AQ
Iconovo and Arcede Pharma take the next step in the development of a new treatment for COPD	11-16	AQ
Arcede Pharma and Iconovo take the next step in the development of a new treatment for COPD	11-16	AQ
BioStock: Arcede Pharma approaches clinical trial after toxicological results	11-14	AQ
BioStock: Arcede Pharma's CEO on the right issue outcome	10/10/23	AQ
BioStock: Arcede hopes to reach larger market than existing drugs	15/08/23	AQ
BioStock Life Science Spring Summit with Arcede Pharma	30/05/23	AQ
BioStock: Arcede approaching dosing in tox study	17/05/23	AQ
BioStock: RSV drugs give hope to COPD patients	28/04/23	AQ
BioStock: Arcede Pharma and Iconovo receive funding from Swelife	04/04/23	AQ
Funding received from Swelife for the development of a new treatment for COPD and severe asthma	31/03/23	AQ
BioStock: Update from Arcede Pharma CEO	23/03/23	AQ
BioStock Investor Meeting with Arcede Pharma	16/03/23	AQ
BioStock: Arcede Pharma looks ahead with strengthened team	15/02/23	AQ
Notice of allowance for patent application of RCD405 in Canada	26/01/23	AQ
BioStock: Arcede Pharma prepares for clinical studies	07/12/22	AQ

No results for this search